BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 38439039)

  • 1. Treatment of recurrent malignant pheochromocytoma with a novel approach: A case report and review of literature.
    Alaswad M; Sabbah BN; Aleem MU; Naguib R; Azzam AZ; Amin TM
    Int J Surg Case Rep; 2024 Apr; 117():109504. PubMed ID: 38503158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular muscle metastasis as the initial presentation of a malignant pheochromocytoma: A unique case.
    Khataminia G; Talaiezadeh A; Bagheri A; Nazari P; Papan AM; Jazayeri N; Baghlani R
    Clin Case Rep; 2020 Sep; 8(9):1689-1692. PubMed ID: 32983478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succinate Dehydrogenase Mutations as Familial Pheochromocytoma Syndromes.
    Lui MS; Clemente-Gutierrez U; Skefos CM; Perrier ND
    Surg Oncol Clin N Am; 2023 Apr; 32(2):289-301. PubMed ID: 36925186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K40E: a novel succinate dehydrogenase (SDH)B mutation causing familial phaeochromocytoma and paraganglioma.
    McDonnell CM; Benn DE; Marsh DJ; Robinson BG; Zacharin MR
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):510-4. PubMed ID: 15473885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric malignant pheochromocytoma with atypical presentation as vision changes, lung metastasis, and recurrence: a case report.
    Zhang K; Yang P; Li M; Xiang P; Cheng Z; Zhou X
    J Med Case Rep; 2024 Mar; 18(1):134. PubMed ID: 38439039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pheochromocytoma associated with a succinate dehydrogenase subunit B mutation: A minireview and a case report.
    Rezkallah E; Elsaify A; Martin V; Viva L; Nag S; Green B; Cheesman M; Elsaify W
    Endocr Regul; 2023 Jan; 57(1):121-127. PubMed ID: 37285461
    [No Abstract]   [Full Text] [Related]  

  • 7. Hereditary pheochromocytoma/paraganglioma syndrome with a novel mutation in the succinate dehydrogenase subunit B gene in a Japanese family: two case reports.
    Hirose R; Tsurutani Y; Sugisawa C; Inoue K; Suematsu S; Nagata M; Hasegawa N; Kakuta Y; Yonamine M; Takekoshi K; Kimura N; Saito J; Nishikawa T
    J Med Case Rep; 2021 May; 15(1):282. PubMed ID: 34020699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
    Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
    Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapsing pheochromocytoma in a Chinese women caused by a novel mutation in exon 6 of the SDHB gene: a case report.
    Reusch J; Haag C; Raue F; Badenhoop K
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):616-8. PubMed ID: 17943698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abdominal nonfunctional paraganglioma in which succinate dehydrogenase subunit B (SDHB) immunostaining was performed: a case report.
    Tanaka T; Joraku A; Ishibashi S; Endo K; Emura M; Kikuchi Y; Shikama A; Kimura N; Shimazui T
    J Med Case Rep; 2023 Mar; 17(1):106. PubMed ID: 36945070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative Recurrences in Patients Operated for Pheochromocytomas and Paragangliomas: New Data Supporting Lifelong Surveillance.
    Parisien-La Salle S; Chbat J; Lacroix A; Perrotte P; Karakiewicz P; Saliba I; Le XK; Olney HJ; Bourdeau I
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local-Regional Recurrence of Pheochromocytoma/Paraganglioma: Characteristics, Risk Factors and Outcomes.
    Cui Y; Ma X; Gao Y; Chang X; Chen S; Lu L; Tong A
    Front Endocrinol (Lausanne); 2021; 12():762548. PubMed ID: 34899602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Clinical Manifestations and Tumor Features Between Metastatic Pheochromocytoma/Paraganglioma Patients With and Without Germline SDHB Mutation.
    Cui Y; Ma X; Wang F; Wang H; Zhou T; Chen S; Tong A; Li Y
    Endocr Pract; 2021 Apr; 27(4):348-353. PubMed ID: 34024343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy.
    Parasiliti-Caprino M; Lucatello B; Lopez C; Burrello J; Maletta F; Mistrangelo M; Migliore E; Tassone F; La Grotta A; Pia A; Reimondo G; Giordano R; Giraudo G; Piovesan A; Ciccone G; Deandreis D; Limone P; Orlandi F; Borretta G; Volante M; Mulatero P; Papotti M; Aimaretti G; Terzolo M; Morino M; Pasini B; Veglio F; Ghigo E; Arvat E; Maccario M
    Hypertens Res; 2020 Jun; 43(6):500-510. PubMed ID: 31586159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.
    Jain A; Baracco R; Kapur G
    Pediatr Nephrol; 2020 Apr; 35(4):581-594. PubMed ID: 30603807
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.